Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European region.
Saved in:
| Title: | Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European region. |
|---|---|
| Authors: | Vancoppenolle J; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Amsterdam, Amsterdam, Netherlands.; Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, Netherlands., Franzen N; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Amsterdam, Amsterdam, Netherlands., Andrianò C; Oncological Pharmacy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Houlind MB; Department of Clinical Research, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark.; The Capital Region Pharmacy, Herlev, Denmark.; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Ćetković Z; University Clinical Center of Serbia, Belgrade, Serbia., Dane A; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, Netherlands., Degrassat-Théas A; Health Law Institute, INSERM UMR S 1145, Paris Cité University, Paris, France.; Faculty of Pharmacy, Paris Cité University, Paris, France., Eldering-Heldens AMP; Department of Pharmacy, Alkmaar, Netherlands., Hug MJ; Medical Center - University of Freiburg, Freiburg, Germany., Knoth H; Pharmacy Department, University Hospital Carl Gustav Carus, Tecnical University Dresden (TUD), Dresden, Germany., Ladisa V; Departement of Hospital Pharmacy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Vajda P; University Pharmacy Department of Pharmacy Administration, Semmelweis University, Budapest, Hungary., Warnke U; Klinikum Ernst von Bergmann GmbH, Potsdam, Germany., Retèl V; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Amsterdam, Amsterdam, Netherlands.; Erasmus School of Health Policy & Management Health Technology Assessment (HTA), Rotterdam, Netherlands.; Organization of European Cancer Institutes (OECI), Brussels, Belgium., van Harten WH; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Amsterdam, Amsterdam, Netherlands.; Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, Netherlands.; Organization of European Cancer Institutes (OECI), Brussels, Belgium. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 Mar 09; Vol. 17, pp. 1736741. Date of Electronic Publication: 2026 Mar 09 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
